Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Thirty Years with HIV Infection-Nonprogression Is Still Puzzling : Lessons to Be Learned from Controllers and Long-Term Nonprogressors. / Gaardbo, Julie C; Hartling, Hans J; Gerstoft, Jan; Poulsen, Susanne Dam.

In: AIDS Research and Treatment, Vol. 2012, 2012, p. 161584.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Gaardbo, JC, Hartling, HJ, Gerstoft, J & Poulsen, SD 2012, 'Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors', AIDS Research and Treatment, vol. 2012, pp. 161584. https://doi.org/10.1155/2012/161584

APA

Gaardbo, J. C., Hartling, H. J., Gerstoft, J., & Poulsen, S. D. (2012). Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors. AIDS Research and Treatment, 2012, 161584. https://doi.org/10.1155/2012/161584

Vancouver

Gaardbo JC, Hartling HJ, Gerstoft J, Poulsen SD. Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors. AIDS Research and Treatment. 2012;2012:161584. https://doi.org/10.1155/2012/161584

Author

Gaardbo, Julie C ; Hartling, Hans J ; Gerstoft, Jan ; Poulsen, Susanne Dam. / Thirty Years with HIV Infection-Nonprogression Is Still Puzzling : Lessons to Be Learned from Controllers and Long-Term Nonprogressors. In: AIDS Research and Treatment. 2012 ; Vol. 2012. pp. 161584.

Bibtex

@article{0c8dbbceecba416189b170b522433d30,
title = "Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors",
abstract = "In the early days of the HIV epidemic, it was observed that a minority of the infected patients did not progress to AIDS or death and maintained stable CD4+ cell counts. As the technique for measuring viral load became available it was evident that some of these nonprogressors in addition to preserved CD4+ cell counts had very low or even undetectable viral replication. They were therefore termed controllers, while those with viral replication were termed long-term nonprogressors (LTNPs). Genetics and virology play a role in nonprogression, but does not provide a full explanation. Therefore, host differences in the immunological response have been proposed. Moreover, the immunological response can be divided into an immune homeostasis resistant to HIV and an immune response leading to viral control. Thus, non-progression in LTNP and controllers may be due to different immunological mechanisms. Understanding the lack of disease progression and the different interactions between HIV and the immune system could ideally teach us how to develop a functional cure for HIV infection. Here we review immunological features of controllers and LTNP, highlighting differences and clinical implications.",
author = "Gaardbo, {Julie C} and Hartling, {Hans J} and Jan Gerstoft and Poulsen, {Susanne Dam}",
year = "2012",
doi = "10.1155/2012/161584",
language = "English",
volume = "2012",
pages = "161584",
journal = "AIDS Research and Treatment",
issn = "2090-1240",
publisher = "Hindawi Publishing Corporation",

}

RIS

TY - JOUR

T1 - Thirty Years with HIV Infection-Nonprogression Is Still Puzzling

T2 - Lessons to Be Learned from Controllers and Long-Term Nonprogressors

AU - Gaardbo, Julie C

AU - Hartling, Hans J

AU - Gerstoft, Jan

AU - Poulsen, Susanne Dam

PY - 2012

Y1 - 2012

N2 - In the early days of the HIV epidemic, it was observed that a minority of the infected patients did not progress to AIDS or death and maintained stable CD4+ cell counts. As the technique for measuring viral load became available it was evident that some of these nonprogressors in addition to preserved CD4+ cell counts had very low or even undetectable viral replication. They were therefore termed controllers, while those with viral replication were termed long-term nonprogressors (LTNPs). Genetics and virology play a role in nonprogression, but does not provide a full explanation. Therefore, host differences in the immunological response have been proposed. Moreover, the immunological response can be divided into an immune homeostasis resistant to HIV and an immune response leading to viral control. Thus, non-progression in LTNP and controllers may be due to different immunological mechanisms. Understanding the lack of disease progression and the different interactions between HIV and the immune system could ideally teach us how to develop a functional cure for HIV infection. Here we review immunological features of controllers and LTNP, highlighting differences and clinical implications.

AB - In the early days of the HIV epidemic, it was observed that a minority of the infected patients did not progress to AIDS or death and maintained stable CD4+ cell counts. As the technique for measuring viral load became available it was evident that some of these nonprogressors in addition to preserved CD4+ cell counts had very low or even undetectable viral replication. They were therefore termed controllers, while those with viral replication were termed long-term nonprogressors (LTNPs). Genetics and virology play a role in nonprogression, but does not provide a full explanation. Therefore, host differences in the immunological response have been proposed. Moreover, the immunological response can be divided into an immune homeostasis resistant to HIV and an immune response leading to viral control. Thus, non-progression in LTNP and controllers may be due to different immunological mechanisms. Understanding the lack of disease progression and the different interactions between HIV and the immune system could ideally teach us how to develop a functional cure for HIV infection. Here we review immunological features of controllers and LTNP, highlighting differences and clinical implications.

U2 - 10.1155/2012/161584

DO - 10.1155/2012/161584

M3 - Journal article

C2 - 22693657

VL - 2012

SP - 161584

JO - AIDS Research and Treatment

JF - AIDS Research and Treatment

SN - 2090-1240

ER -

ID: 48451883